Balsara J J, Bapat T R, Chandorkar A G
Indian J Physiol Pharmacol. 1980 Jul-Sep;24(3):227-32.
Piracetam, 2-oxo-1-pyrrolidine acetamide (Nootropil), is a cyclic GABA analogue. As GABA-mimetic compounds have been reported to potentiate haloperidol-induced catalepsy it was decided to study the effect of piracetam on haloperidol-induced catalepsy in rats. Piracetam, in high doses, was found to induce catalepsy while sub-cataleptic doses of piracetam were found to potentiate haloperidol-induced catalepsy. Piracetam, however, failed to antagonise apomorphine stereotypy in rats thereby ruling out the possibility of its possessing dopamine receptor blocking activity. The possible mechanism involved in the induction of catalepsy by piracetam and in the potentiation of haloperidol-induced catalepsy by sub-cataleptic doses of piracetam is discussed on the basis of its chemical relationship to GABA.
吡拉西坦,即2-氧代-1-吡咯烷乙酰胺(脑复康),是一种环状GABA类似物。由于据报道GABA模拟化合物可增强氟哌啶醇诱导的僵住症,因此决定研究吡拉西坦对大鼠氟哌啶醇诱导的僵住症的影响。发现高剂量的吡拉西坦可诱发僵住症,而亚致僵剂量的吡拉西坦可增强氟哌啶醇诱导的僵住症。然而,吡拉西坦未能拮抗大鼠的阿扑吗啡刻板行为,从而排除了其具有多巴胺受体阻断活性的可能性。基于吡拉西坦与GABA的化学关系,讨论了吡拉西坦诱发僵住症以及亚致僵剂量的吡拉西坦增强氟哌啶醇诱导的僵住症可能涉及的机制。